Epigenetic Reprogramming: The Most Exciting Frontier in Longevity Science

Partial epigenetic reprogramming has produced extraordinary results in animal models, reversing biological age markers and restoring function in aged tissues. Improve how you understand where this technology genuinely stands and what its realistic timeline to human application looks like. Take away specific solutions to:

• Unpack the science behind Yamanaka factor reprogramming, what it has demonstrated in preclinical research and why translation to humans is far more complex
• Evaluate the companies and research programmes at the forefront of epigenetic reprogramming and assess their clinical credibility and development timelines
• Position your understanding of reprogramming science to make informed decisions as therapies move closer to human trials and eventual clinical access

Achieve a sophisticated grasp of longevity science’s most transformative frontier, grounded in what the evidence actually shows today